Presented by




Sponsored by


Emerging Medical Technology Symposium
Wednesday, March 3, 2010

Wednesday, March 3, 2010
a Special Event @ InnoTech
11:30pm - 4:30pm

Norris Conference Center

**IMPORTANT NOTE:  YOUR REGISTRATION FOR
THE EMERGING MEDICAL TECHNOLOGY SYMPOSIUM ON 3/3/2010
INCLUDES ADMISSION TO INNOTECH ON THURSDAY 3/4/2010**


11:30am - 1:00pm             
Opening Keynote & Lunch

Challenging Times for Early Stage MedTech


featuring
Paul K. Nichols, Jr.

President and CEO
TRINITY ORTHOPEDICS, LLC


Mr. Nichols is a 32 year veteran of the medical device industry and a successful
executive and entrepreneur in the musculoskeletal sector since 1985. 
Between 1995 and 2005 he founded three companies focused in technology for
reconstructive surgery of the extremities, defining a new industry segment that now exceeds
$1 billion in annual sales.  Mr. Nichols is currently a director of BIO2, ITS-USA and Trinity
Orthopedics, where he also serves as President.

1:00pm - 2:00pm
Three Sessions

(in THREE distinct categories):

CHASING THE MONEY 
BUSINESS NIMBLENESS IN THE MARKETPLACE
Funding Sources

Jay Campion
Co-founder & Managing Director
ACCESS VENTURE PARTNERS

John C. Kerr
Principal
MOORMAN KERR INTERESTS

Andrew A. Nat, Jr.
Executive Director
TEXAS LIFE SCIENCE CENTER

Session Moderated by:
Joseph (Joey) D. Oliver III
COO & CFO
ENTrigue Surgical, Inc.
Intellectual Property

Matthew S. Crawford, MBA
Founding Managing Director
PTV SCIENCES

Michael R. Samardzija, PhD
Counsel
BRACEWELL & GIULIANI LLP

Mark B. Wilson, JD
Partner
FULBRIGHT & JAWORSKI LLP

Session Moderated by:
Ian Clements, MSc
Co-Founder & CEO
VIROXIS CORPORATION

Reimbursement
& Regulatory Issues


Allen M. Fredrickson, MCE
President/CEO
SIGNATURE PERFORMANCE

Edgar "Jed" C. Morrison, Jr., JD
Partner
JACKSON WALKER, LLP

Jaye Thompson, PhD
Senior Vice President
Clinical Development and Regulatory Affairs
OPEXA THERAPEUTICS, INC.

Session Moderated by:
Mark Q. Niederauer, Ph.D.
Chief Technology Officer
EO2 CONCEPTS

2:15pm - 3:15pm       
  
Three sessions
(in three distinct categories):


CHASING THE MONEY
BUSINESS
NIMBLENESS IN THE MARKETPLACE
Lessons Learned:
CEO Panel Discussion
of the Good,
the Bad & the Ugly

Dennis McWilliams
CEO & Founder
APOLLO ENDOSURGERY

Ted Terrazas
Founder & President
TERRAHEALTH, INC. (THI)

Jay Webster
Chief Product Officer
QUOVA, INC.

Session Moderated by:
Ruben G. Zamorano
President
DIABETICA SOLUTIONS, INC.

   

General Business
Practices:
Accounting, Contracting
w/ Govt Facilities,
Exit Strategies,
Talent Acquisition, etc.

Ryan M. Confer
Chief Operating Officer
INNOVATE TEXAS FOUNDATION

Steve Cook, CPA
Managing Shareholder
COOK AND ASSOCIATES CPA

Brigitta Glick

President
PROVENIR, LLC

J. Bruce Hughes
Project Manager for Technology Commercialization
SATAI & SOUTH TEXAS REGIONAL CENTER FOR INNOVATION & COMMERCIALIZATION

Session Moderated by:
Ann Beal Salamone
President
ROCHAL INDUSTRIES
Adapting to Change

Scott Kaeppel
President
KAEPPEL CONSULTING, LLC

Brian Windsor, PhD
Senior Vice President of Portfolio Company Management
EMERGENT TECHNOLOGIES, INC.

David G. Young, III, MD
FACP, Brig Gen USAF (Ret) / President & CEO
REES GROUP

Session Moderated by:
Daniel R. Lee
Chief Executive Officer
APERION BIOLOGICS, INC.

3:30pm - 4:30pm
Closing/Integrated Session

The Emerging Medical Technology co-chairs:
  
Gabriele G. Niederauer, PhD
Vice President,
Research & Development
ENTrigue SURGICAL, INC.
Don Taylor, Col. USAF Ret
President
TEAM
INTEGRATED ENGINEERING, INC.

Join the event co-chairs as they moderate/lead this interactive, closing Integrated Track to bring the
day's sessions to a cohesive conclusion. 

This session will include and investigation, discussion and exploration of:
  • Opportunities in San Antonio
  • The existing marketplace needs
  • The current incentives being offered the local, state and federal  
  • i.     BRAC
  • ii.    EMR/EHR stimulus

4:30pm - 5:00pm 
   
Jim Brazell presents "The History of Innovation in San Antonio"

5:00pm - 5:45pm
Panel discussion on "The Future of Innovation & Entrepreneurship in San Antonio"
Moderated by Cory Hallam, PhD, Director, Center for Innovation and Technology Entrepreneurship at UTSA

With Panelists:
Fred Dinger, President & CEO of ENTrigue Surgical, Inc.
York Duncan, President of the Texas Research Park Foundation
Dr. Randy Goldsmith, PhD, President and CEO of the Mississippi Technology Alliance
Steve Lutz, Executive Director, AT&T, 2010 Chairman of the Board of SATAI &
Greater San Antonio Chamber of Commerce Technology Committee Chair for 2010

5:30pm - 8:00pm
Technology Connexus "Connections"
Networking mixer and Technology Showcase featuring new companies, new ideas and more. 
Includes hors d'oeuvres and cocktails.

Including the following Emerging Medical Technology Companies:
America Stem Cell, Inc.  ENTrigue Surgical, Inc.
ViroXis Corporation
Aperion Biologics, Inc.
Paragonix Technologies, LP   
Voxelogix
Azaya Therapeutics, Inc.    
Rochal Industries
Y2 Solutions

The $39.00 per registrant fee for the Emerging Medical Technology Symposium, a special event
in conjunction with InnoTech, includes lunch and the Emerging Medical Technology Symposium
sessions on Wednesday, March 3, 2010. 

Also includes complimentary admission to InnoTech on Thursday, March 4, 2010.


PRINCIPAL SPONSOR






SUPPORTING SPONSORS


                                



Thank you to the Emerging Medical Technology Advisory Board
for lending their time & expertise to the event:

Diana L. Faulkner, MBA, PMP
President
iFUSION STRATEGIES, LLC

James H. Hayes, MHA
Chairman of the Board
APPLIED MEASUREMENT PROFESSIONALS, INC.
DeEnna Jensen
Business Development
TEAM INTEGRATED ENGINEERING, INC.
Roxanne Jemeyson
Vice President, Information Technology
& Engineering
TERRAHEALTH, INC.
Daniel R. Lee
Chief Executive Officer
APERION BIOLOGICS, INC.
Matt Scherer
Owner
SCHERER COMMUNICATIONS